PATENT CLAIM ANALYSIS

Application Number: 15899061
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "210180"]

Abstract:
A compound of formula I, or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.

Claim (Index 4):
The compound as claimed in  claim 1 , wherein\n W 8  and W 10  each represents hydrogen; and W 9  represents halogen, \u2014R as , \u2014CN, \u2014C(O)R b3 , \u2014C(O)N(R c3 )R d3 , \u2014C(O)OR e3 , \u2014N(R f3 )R g3 , \u2014N(R h3 )C(O)R i3 , \u2014N(R j3 )C(O)OR k3 , \u2014N(R l3 )C(O)N(R m3 )R n3 , \u2014N(R o3 )S(O) 2 R p3 , \u2014OR q3x , \u2014S(O) m R t3 , \u2014S(O) 2 N(R u3 )R v3 , heterocycloalkyl optionally substituted by one or more substituents selected from G 1 , aryl optionally substituted by one or more substituents selected from G 2 , or heteroaryl optionally substituted by one or more substituents selected from G 2 .

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14647400', '15447818', '15315461', '15315478', '11123755']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8000151067922976
- 35 USC 102 Novelty (BERT): 0.5974752110577253
- Combined Prediction Score: 0.7797611172188403
- Mean Citation Score: 440.228286
- Max Citation Score: 523.1518
- Similarity Product: 437.69913917932513

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test